Active Supportive Care and Symptom Management Grants

PI Name Organization - Company Title FOAsort descending
Kleckner, Ian Robert University Of Maryland Baltimore Effects of exercise during platinum chemotherapy on neuropathy: examining the interoceptive brain system and inflammation PAR-20-292: NCI Clinical and Translational Exploratory/Developmental Studies
Tamrazi, Benita Children'S Hospital Of Los Angeles Brain iron accumulation as an in vivo quantifiable biomarker of neurocognitive dysfunction in pediatric brain tumor survivors PAR-20-292: NCI Clinical and Translational Exploratory/Developmental Studies
Yennu, Sriram University Of Tx Md Anderson Can Ctr Opioid-Sparing Interdisciplinary Interventions Addressing Pain in Head and Neck Cancer Patients PAR-20-292: NCI Clinical and Translational Exploratory/Developmental Studies
Perlis, Michael Lloyd University Of Pennsylvania The Association Between CBT-I Dose, Sleep Duration, and Fatigue in Breast Cancer Patients PAR-20-292: NCI Clinical and Translational Exploratory/Developmental Studies
Rini, Christine Northwestern University At Chicago Web-based Pain Coping Skills Training to Improve Pain and Poor Adherence caused by Aromatase Inhibitor-Associated Arthralgia In Breast Cancer Survivors (SKIP-Arthralgia): A Randomized Controlled Trial PAR-21-035: Cancer Prevention and Control Clinical Trials Grant Program
Ross, Stephen New York University School Of Medicine Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress PAR-21-035: Cancer Prevention and Control Clinical Trials Grant Program
Sohl, Stephanie Jean Wake Forest University Health Sciences REmotely-delivered Supportive Programs for Improving surgical pain and disTrEss (RESPITE) PAR-21-035: Cancer Prevention and Control Clinical Trials Grant Program
Hu, Jim Weill Medical Coll Of Cornell Univ Pelvic fascia spARing radical prostatectomy TrIAL (PARTIAL) PAR-21-035: Cancer Prevention and Control Clinical Trials Grant Program
Valdimarsdottir, Heiddis Icahn School Of Medicine At Mount Sinai Systematic Light Exposure Effects on Circadian Rhythms Entrainment, Inflammation, Neutropenic Fever and Symptom Burden among Multiple Myeloma Patients undergoing Autologous Stem Cell Transplantation PAR-21-035: Cancer Prevention and Control Clinical Trials Grant Program
Prigerson, Holly Gwen Weill Medical Coll Of Cornell Univ Behavioral and Psychosocial Effects on Study Outcomes in End-Stage Cancer Treatment (BEST End-Stage Cancer Study) PAR-21-333: NCI Outstanding Investigator Award
Grace, Peter University Of Tx Md Anderson Can Ctr PQ12 Targeting HDAC6 for Chemotherapy-Induced Neuropathy and Chemobrain RFA-CA-17-017: Research Answers to NCI's Provocative Questions
Tighiouart, Mourad Cedars-Sinai Medical Center Advancing Analysis and Interpretation ofAdverse Events and PROs in Cancer Clinical Trials RFA-CA-17-052: Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability
Basch, Ethan M. Univ Of North Carolina Chapel Hill Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability RFA-CA-17-052: Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability
Gray, Robert J Dana-Farber Cancer Inst Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV) RFA-CA-17-052: Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability
Mohile, Supriya G University Of Rochester Understanding Treatment Tolerability in Older Patients with Cancer RFA-CA-17-052: Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability

Pages